HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Application of low-molecular-weight heparin during pregnancy and delivery in case of reproductive failure due to antiphospholipid syndrome].

Abstract
The authors report the results of application of low molecular weight heparin during pregnancy, delivery and after birth to counter placental insufficiency in case of primary antiphospholipid syndrome. The patient had been treated with Fraxiparin for 126 days. No systemic or local side effects were spotted. There were no genital bleeding and tromboembolic accidents during pregnancy. A Caesaerean section was carried out under spinal anaesthesia. Fraxiparin treatment was not halted during the section, which was accompanied by a normal blood loss. The pregnancy yielded an eutrophic newborn and no complications were demonstrated during the neonatal period.
AuthorsZh Karag'ozova, T Chernev, Z Iankova, M Baleva, A Dimitrov
JournalAkusherstvo i ginekologiia (Akush Ginekol (Sofiia)) Vol. 39 Issue 3 Pg. 48-51 ( 2000) ISSN: 0324-0959 [Print] Bulgaria
Vernacular TitlePrilozhenie na niskomolekuliaren kheparin po vreme na bremennost i razhdane pri sluchai na reproduktivni neblagopoluchiia, sv'rzani s p'rvichen antifosfolipiden sindrom.
PMID11187998 (Publication Type: Case Reports, English Abstract, Journal Article, Review)
Chemical References
  • Heparin, Low-Molecular-Weight
  • Nadroparin
Topics
  • Adult
  • Antiphospholipid Syndrome (drug therapy)
  • Blood Coagulation (drug effects)
  • Cesarean Section
  • Female
  • Heparin, Low-Molecular-Weight (therapeutic use)
  • Humans
  • Nadroparin (therapeutic use)
  • Pregnancy
  • Pregnancy Complications (drug therapy, prevention & control)
  • Pregnancy Outcome
  • Premedication
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: